The costs of vaping ought to be reduced for smokers in developing countries as an urgent “human rights issue”, scientific study has told a pro-tobacco conference in London.
Addressing a 300-strong audience of tobacco and vaping industry representatives, Helen Redmond, a professional in substance use at New York University’s Silver School of Social Work, said folks poor countries must not be priced from nicotine-based products that could potentially help them to to give up smoking.
Redmond compared the medicinal qualities of nicotine with cannabis and stressed “the have to get vaping for the poorest, who need it most”.
“It’s a human rights issue – being a harm reduction device, prices need to fall,” she said. “Nicotine will not be a dirty drug, it can help with depression and anxiety.”
Academics on the 2018 global tobacco and nicotine forum called for further research into the possible medical benefits of nicotine along with a focus on the development of innovative nicotine-based products that can provide a “smoke-free society” and minimize the harmful effects of cigarettes.
Viscount Matt Ridley, an author and member of the home of Lords, joined the chorus of experts promoting vaping as a kind of harm reduction, arguing that subjecting top rated electronic cigarette towards the same workplace restrictions as smoking may be thought of as an infringement of an individual’s human rights.
“We should treat vaping in the same manner that we treat access to cellphones,” said Ridley. “The best way to get people to give up [smoking] is to innovate with technology”.
Ridleytold the conference that, inspite of the industry’s continued concentrate on promoting nicotine-based products as a kind of harm reduction, public opinion was moving away from vaping because of media “scare stories”. He compared the industry’s plight, specifically in america, to that faced by “bootleggers and baptists during prohibition”.
Clive Bates, director of advocacy group Counterfactual, described the views of anti-tobacco campaigners as “hostile and focused”, accusing them of obtaining rival commercial interests using a goal of “annihilating” the market. Warning of the damage due to “those having a vested interest in causing alarm”, he stated that although critics laboured to produce evidence to “maintain the narrative of harm”, technological advances meant the transition to vape-type products was likely to become mandatory rather than voluntary.
You will find 1.1 billion smokers worldwide and 6 million die each year as being a direct reaction to smoking. An additional 890,000 people a year die prematurely as a result of second-hand smoke, according to the World Health Organization.
A single cigarette contains more than 200 carcinogenic chemicals, as well as the addictive stimulant nicotine. Scientists and academics have so far did not reach agreement on advantages and disadvantages of long-term nicotine use.
At a plenary session, clinical psychologist Karl Fagerström called for research to the positive benefits of nicotine, which he believes can assist people experiencing Alzheimer’s and depression. Also, he advised wgferg the business should move from combustible to nicotine-based products.
“No the initial one is interested in establishing what the benefits of smoking nicotine are,” Fagerström said.
Martin Jarvis, professor of health psychology at University College London, saidthe US was moving towards prohibition-type enforcement, with all the Food and Drug Administration keen to reduce the level of nicotine in cigarettes.
“Society doesn’t understand nicotine,” said Jarvis, “because they believe that it is particularly bad.”
But Jarvis said “describing nicotine as being addictive is justified”, adding that “80% of smokers wished they never started”.